Molecularly-Targeted and Biological Anti-Cancer Therapy

被引：1
|
作者：
Klener, P., Jr. [1 ,2 ,3 ,4 ]
Klener, P. [1 ,2 ,3 ,4 ]
机构：
[1] Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague 12853 2, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Ctr Expt Haematol, Prague 12853 2, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Dept Med 1, Dept Haematol, Prague 12853 2, Czech Republic
[4] Gen Univ Hosp, Prague, Czech Republic
来源：
FOLIA BIOLOGICA | 2012年 / 58卷 / 01期
关键词：
targeted therapy; biological therapy; biopharmaceutical; biosimilar; tailored therapy; personalized medicine; ANTIBODIES; CD20;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1 / 6
页数：6
相关论文
共 50 条
  • [31] Molecularly-Targeted Strategy and NF-xB in Lymphoid Malignancies
    Horie, Ryouichi
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2013, 53 (03) : 185 - 195
  • [32] Establishing a Model to Identify Mutant Subpopulations That Cause Resistance to Molecularly-Targeted Cancer Therapies.
    Banda, M.
    Mckim, K. L.
    Parsons, B. L.
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2016, 57 : S75 - S75
  • [33] Molecularly targeted therapy and cancer surgery
    Judson, I.
    Barriuso, J.
    [J]. BRITISH JOURNAL OF SURGERY, 2008, 95 (05) : 537 - 538
  • [34] Molecularly targeted therapy for gastrointestinal cancer
    Wiedmann, MW
    Caca, K
    [J]. CURRENT CANCER DRUG TARGETS, 2005, 5 (03) : 171 - 193
  • [35] Targeted anti-cancer therapies for renal cancer
    Amato, Robert J.
    Jac, Jaroslaw
    [J]. DRUGS, 2006, 66 (17) : 2161 - 2171
  • [36] Strategies to optimize the promise of checkpoint-targeted anti-cancer therapy
    Rapoport, Bernardo L.
    Anderson, Ronald
    [J]. IMMUNOTHERAPY, 2024, 16 (09) : 565 - 568
  • [37] Use of the Rad51 promoter for targeted anti-cancer therapy
    Hine, Christopher M.
    Seluanov, Andrei
    Gorbunova, Vera
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (52) : 20810 - 20815
  • [38] Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy
    Savonarola, A.
    Palmirotta, R.
    Guadagni, F.
    Silvestris, F.
    [J]. PHARMACOGENOMICS JOURNAL, 2012, 12 (04): : 277 - 286
  • [39] Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy
    Di Francia, Raffaele
    De Monaco, Angela
    Saggese, Mariangela
    Iaccarino, Giancarla
    Crisci, Stefania
    Frigeri, Ferdinando
    De Filippi, Rosaria
    Berretta, Massimiliano
    Pinto, Antonio
    [J]. CURRENT CANCER DRUG TARGETS, 2018, 18 (05) : 499 - 511
  • [40] Characterization of platinum-protein conjugates for targeted anti-cancer therapy
    Krause, Mary E.
    Mills, Brittney J.
    Laurence, Jennifer S.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
12345